Bio Essence Corporation
BIOE
$0.19
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.52M | 1.31M | 896.20K | -160.50K | -1.37M |
| Total Depreciation and Amortization | 103.90K | 400.00 | 400.00 | 600.00 | 600.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.70K | 32.90K | 41.90K | 50.40K | 1.27M |
| Change in Net Operating Assets | -569.30K | -156.60K | 631.50K | 861.40K | 1.02M |
| Cash from Operations | 1.08M | 1.18M | 1.57M | 751.80K | 921.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00 | -100.00 |
| Other Investing Activities | -84.80K | -- | -- | -- | -- |
| Cash from Investing | -84.80K | -- | -- | -100.00 | -100.00 |
| Total Debt Issued | 342.80K | 852.20K | 769.20K | 333.00K | 241.20K |
| Total Debt Repaid | -1.77M | -2.44M | -2.34M | -1.09M | -1.17M |
| Issuance of Common Stock | 440.00K | 440.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | -990.20K | -1.15M | -1.57M | -752.80K | -931.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 700.00 | 36.20K | -1.40K | -1.30K | -9.70K |